Dr. Mark Joseph Burish, MD

Dr. Burish practices at Houston Plastic and Craniofacial Surgery Center in Houston, Texas.

Dr. Burish's NPI, 1154645653, was assigned on March 26, 2010. Dr. Burish graduated from Vanderbilt University School Of Medicine in 2010. Dr. Burish holds Texas license Q6158.

Dr. Burish's primary practice is Houston Plastic and Craniofacial Surgery Center, at 6400 Fannin St, Houston, TX 77030 in Harris County. The practice phone is (713) 791-0700.

Dr. Burish's primary practice is Houston Plastic and Craniofacial Surgery Center in Houston, Texas. Dr. Burish is also affiliated with Memorial Hermann-Texas Medical Center. The medical group on file is UTHealth Houston Neurosciences, Texas Medical Center. Dmand AI also links Dr. Burish to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Burish practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Burish's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Burish is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Burish's licenses on file in 3 states: Texas, California and Louisiana.

Dmand AI lists fibromyalgia and chronic pain, lower back pain, migraine and chronic headache and thoracic spine disorders among the conditions Dr. Burish treats.

CMS data shows 57 Medicare services from Dr. Burish across 1 procedure code in 2024, all of them office visits, for 58 Medicare patients. Medicare paid $5,204 for them. Every service was in an office.

CMS counts 58 Medicare patients who saw Dr. Burish in 2024. The largest group is 65 to 74, with 27 patients. 72% of them have high blood pressure, and 71% have high cholesterol. Their average risk score is 1.10, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Burish's median patient age at 54, with 64% women.

In 2024, Dr. Burish wrote 1,275 Medicare Part D claims for 128 patients. 79% of them were for generic drugs. CMS names the drug for 1,051 of them, across 31 drugs with 11 or more claims each, at $353,232 in total drug cost. In 2023, CMS named 708 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Burish for performance year 2024, reported as part of a group. Dr. Burish accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Burish as offering telehealth.

Dmand AI links 60 papers to Dr. Burish, published from 2003 to 2025. 2021 was the busiest year, with 9. The most frequent topics are Cluster Headache, Somatosensory Cortex and Headache. Dr. Burish has published most often in Headache. Dr. Burish's most frequent co-authors are Jessica Ailani, MD, Kathleen B. Digre, MD and David W. Dodick, MD.

Dmand AI links Dr. Burish to 1 clinical trial. Conditions studied include Cluster Headache and Trigeminal Autonomic Cephalalgias.

CMS Open Payments shows 41 general payments to Dr. Burish from 15 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 52% of the total. Pfizer Inc. paid the most, $11,003.

Dr. Burish graduated from Vanderbilt University School Of Medicine in 2010. Dr. Burish is a member of AAN.

Dr. Burish is in network with 21 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Cigna. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.